Sabarubicin (MEN-10755) a disaccharide analog of doxorubicin is used for the treatment of small cell lung cancer (SCLC). It has been seen to show superior antitumour efficacy which is purported to be linked to the activation of p53-independent apoptosis.
This page contains content from the copyrighted Wikipedia article "Sabarubicin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
